Selected research
Industry Research
Irreversible Hydrocolloid Industry Research Report 2026
Market perspective
The global Irreversible Hydrocolloid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Irreversible Hydrocolloid is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Irreversible Hydrocolloid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Irreversible Hydrocolloid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Irreversible Hydrocolloid include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Irreversible Hydrocolloid market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Irreversible Hydrocolloid.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Irreversible Hydrocolloid Market by Company
Zhermack
Ultradent Products
Septodont
Monitex Industrial
Lascod
Kulzer
Kerr
Ivoclar
Hygedent
Hager & Werken
GC Corporation
Elsodent
DUX Dental
Dentsply Sirona
Dentamerica
Cavex
Irreversible Hydrocolloid Segment by Type
Regular-set Type
Fast-set Type
Irreversible Hydrocolloid Segment by Application
Dental Clinics
Dental Education
Others
Irreversible Hydrocolloid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Hydrocolloid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irreversible Hydrocolloid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Hydrocolloid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Irreversible Hydrocolloid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Irreversible Hydrocolloid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Irreversible Hydrocolloid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Regular-set Type
- Fast-set Type
Applications
- Dental Clinics
- Dental Education
- Others
Companies covered
- Zhermack
- Ultradent Products
- Septodont
- Monitex Industrial
- Lascod
- Kulzer
- Kerr
- Ivoclar
- Hygedent
- Hager & Werken
- GC Corporation
- Elsodent
- DUX Dental
- Dentsply Sirona
- Dentamerica
- Cavex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Irreversible Hydrocolloid by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Regular-set Type
- 2.2.3 Fast-set Type
- 2.3 Irreversible Hydrocolloid by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dental Clinics
- 2.3.3 Dental Education
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Irreversible Hydrocolloid Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Irreversible Hydrocolloid Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Irreversible Hydrocolloid Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Irreversible Hydrocolloid Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Irreversible Hydrocolloid Production by Manufacturers (2021-2026)
- 3.2 Global Irreversible Hydrocolloid Production Value by Manufacturers (2021-2026)
- 3.3 Global Irreversible Hydrocolloid Average Price by Manufacturers (2021-2026)
- 3.4 Global Irreversible Hydrocolloid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Irreversible Hydrocolloid Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Irreversible Hydrocolloid Manufacturers, Product Type & Application
- 3.7 Global Irreversible Hydrocolloid Manufacturers Established Date
- 3.8 Global Irreversible Hydrocolloid Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhermack
- 4.1.1 Zhermack Irreversible Hydrocolloid Company Information
- 4.1.2 Zhermack Irreversible Hydrocolloid Business Overview
- 4.1.3 Zhermack Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Zhermack Product Portfolio
- 4.1.5 Zhermack Recent Developments
- 4.2 Ultradent Products
- 4.2.1 Ultradent Products Irreversible Hydrocolloid Company Information
- 4.2.2 Ultradent Products Irreversible Hydrocolloid Business Overview
- 4.2.3 Ultradent Products Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Ultradent Products Product Portfolio
- 4.2.5 Ultradent Products Recent Developments
- 4.3 Septodont
- 4.3.1 Septodont Irreversible Hydrocolloid Company Information
- 4.3.2 Septodont Irreversible Hydrocolloid Business Overview
- 4.3.3 Septodont Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Septodont Product Portfolio
- 4.3.5 Septodont Recent Developments
- 4.4 Monitex Industrial
- 4.4.1 Monitex Industrial Irreversible Hydrocolloid Company Information
- 4.4.2 Monitex Industrial Irreversible Hydrocolloid Business Overview
- 4.4.3 Monitex Industrial Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Monitex Industrial Product Portfolio
- 4.4.5 Monitex Industrial Recent Developments
- 4.5 Lascod
- 4.5.1 Lascod Irreversible Hydrocolloid Company Information
- 4.5.2 Lascod Irreversible Hydrocolloid Business Overview
- 4.5.3 Lascod Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Lascod Product Portfolio
- 4.5.5 Lascod Recent Developments
- 4.6 Kulzer
- 4.6.1 Kulzer Irreversible Hydrocolloid Company Information
- 4.6.2 Kulzer Irreversible Hydrocolloid Business Overview
- 4.6.3 Kulzer Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Kulzer Product Portfolio
- 4.6.5 Kulzer Recent Developments
- 4.7 Kerr
- 4.7.1 Kerr Irreversible Hydrocolloid Company Information
- 4.7.2 Kerr Irreversible Hydrocolloid Business Overview
- 4.7.3 Kerr Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Kerr Product Portfolio
- 4.7.5 Kerr Recent Developments
- 4.8 Ivoclar
- 4.8.1 Ivoclar Irreversible Hydrocolloid Company Information
- 4.8.2 Ivoclar Irreversible Hydrocolloid Business Overview
- 4.8.3 Ivoclar Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Ivoclar Product Portfolio
- 4.8.5 Ivoclar Recent Developments
- 4.9 Hygedent
- 4.9.1 Hygedent Irreversible Hydrocolloid Company Information
- 4.9.2 Hygedent Irreversible Hydrocolloid Business Overview
- 4.9.3 Hygedent Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Hygedent Product Portfolio
- 4.9.5 Hygedent Recent Developments
- 4.10 Hager & Werken
- 4.10.1 Hager & Werken Irreversible Hydrocolloid Company Information
- 4.10.2 Hager & Werken Irreversible Hydrocolloid Business Overview
- 4.10.3 Hager & Werken Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Hager & Werken Product Portfolio
- 4.10.5 Hager & Werken Recent Developments
- 4.11 GC Corporation
- 4.11.1 GC Corporation Irreversible Hydrocolloid Company Information
- 4.11.2 GC Corporation Irreversible Hydrocolloid Business Overview
- 4.11.3 GC Corporation Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 GC Corporation Product Portfolio
- 4.11.5 GC Corporation Recent Developments
- 4.12 Elsodent
- 4.12.1 Elsodent Irreversible Hydrocolloid Company Information
- 4.12.2 Elsodent Irreversible Hydrocolloid Business Overview
- 4.12.3 Elsodent Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Elsodent Product Portfolio
- 4.12.5 Elsodent Recent Developments
- 4.13 DUX Dental
- 4.13.1 DUX Dental Irreversible Hydrocolloid Company Information
- 4.13.2 DUX Dental Irreversible Hydrocolloid Business Overview
- 4.13.3 DUX Dental Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 DUX Dental Product Portfolio
- 4.13.5 DUX Dental Recent Developments
- 4.14 Dentsply Sirona
- 4.14.1 Dentsply Sirona Irreversible Hydrocolloid Company Information
- 4.14.2 Dentsply Sirona Irreversible Hydrocolloid Business Overview
- 4.14.3 Dentsply Sirona Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Dentsply Sirona Product Portfolio
- 4.14.5 Dentsply Sirona Recent Developments
- 4.15 Dentamerica
- 4.15.1 Dentamerica Irreversible Hydrocolloid Company Information
- 4.15.2 Dentamerica Irreversible Hydrocolloid Business Overview
- 4.15.3 Dentamerica Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Dentamerica Product Portfolio
- 4.15.5 Dentamerica Recent Developments
- 4.16 Cavex
- 4.16.1 Cavex Irreversible Hydrocolloid Company Information
- 4.16.2 Cavex Irreversible Hydrocolloid Business Overview
- 4.16.3 Cavex Irreversible Hydrocolloid Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Cavex Product Portfolio
- 4.16.5 Cavex Recent Developments
5 Global Irreversible Hydrocolloid Production by Region
- 5.1 Global Irreversible Hydrocolloid Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Irreversible Hydrocolloid Production by Region: 2021-2032
- 5.2.1 Global Irreversible Hydrocolloid Production by Region: 2021-2026
- 5.2.2 Global Irreversible Hydrocolloid Production Forecast by Region (2027-2032)
- 5.3 Global Irreversible Hydrocolloid Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Irreversible Hydrocolloid Production Value by Region: 2021-2032
- 5.4.1 Global Irreversible Hydrocolloid Production Value by Region: 2021-2026
- 5.4.2 Global Irreversible Hydrocolloid Production Value Forecast by Region (2027-2032)
- 5.5 Global Irreversible Hydrocolloid Market Price Analysis by Region (2021-2026)
- 5.6 Global Irreversible Hydrocolloid Production and Value, YOY Growth
- 5.6.1 North America Irreversible Hydrocolloid Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Irreversible Hydrocolloid Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Irreversible Hydrocolloid Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Irreversible Hydrocolloid Production Value Estimates and Forecasts (2021-2032)
6 Global Irreversible Hydrocolloid Consumption by Region
- 6.1 Global Irreversible Hydrocolloid Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Irreversible Hydrocolloid Consumption by Region (2021-2032)
- 6.2.1 Global Irreversible Hydrocolloid Consumption by Region: 2021-2026
- 6.2.2 Global Irreversible Hydrocolloid Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Irreversible Hydrocolloid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Irreversible Hydrocolloid Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Irreversible Hydrocolloid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Irreversible Hydrocolloid Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Irreversible Hydrocolloid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Irreversible Hydrocolloid Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Irreversible Hydrocolloid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Irreversible Hydrocolloid Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Irreversible Hydrocolloid Production by Type (2021-2032)
- 7.1.1 Global Irreversible Hydrocolloid Production by Type (2021-2032) & (t)
- 7.1.2 Global Irreversible Hydrocolloid Production Market Share by Type (2021-2032)
- 7.2 Global Irreversible Hydrocolloid Production Value by Type (2021-2032)
- 7.2.1 Global Irreversible Hydrocolloid Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Irreversible Hydrocolloid Production Value Market Share by Type (2021-2032)
- 7.3 Global Irreversible Hydrocolloid Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Irreversible Hydrocolloid Production by Application (2021-2032)
- 8.1.1 Global Irreversible Hydrocolloid Production by Application (2021-2032) & (t)
- 8.1.2 Global Irreversible Hydrocolloid Production Market Share by Application (2021-2032)
- 8.2 Global Irreversible Hydrocolloid Production Value by Application (2021-2032)
- 8.2.1 Global Irreversible Hydrocolloid Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Irreversible Hydrocolloid Production Value Market Share by Application (2021-2032)
- 8.3 Global Irreversible Hydrocolloid Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Irreversible Hydrocolloid Value Chain Analysis
- 9.1.1 Irreversible Hydrocolloid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Irreversible Hydrocolloid Production Mode & Process
- 9.2 Irreversible Hydrocolloid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Irreversible Hydrocolloid Distributors
- 9.2.3 Irreversible Hydrocolloid Customers
10 Global Irreversible Hydrocolloid Analyzing Market Dynamics
- 10.1 Irreversible Hydrocolloid Industry Trends
- 10.2 Irreversible Hydrocolloid Industry Drivers
- 10.3 Irreversible Hydrocolloid Industry Opportunities and Challenges
- 10.4 Irreversible Hydrocolloid Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst